U.S. flag

An official website of the United States government

NM_001008216.2(GALE):c.151C>T (p.Arg51Trp) AND UDPglucose-4-epimerase deficiency

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
Dec 4, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001265572.12

Allele description [Variation Report for NM_001008216.2(GALE):c.151C>T (p.Arg51Trp)]

NM_001008216.2(GALE):c.151C>T (p.Arg51Trp)

Gene:
GALE:UDP-galactose-4-epimerase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.11
Genomic location:
Preferred name:
NM_001008216.2(GALE):c.151C>T (p.Arg51Trp)
HGVS:
  • NC_000001.11:g.23798701G>A
  • NG_007068.1:g.7104C>T
  • NM_000403.4:c.151C>T
  • NM_001008216.2:c.151C>TMANE SELECT
  • NM_001127621.2:c.151C>T
  • NP_000394.2:p.Arg51Trp
  • NP_001008217.1:p.Arg51Trp
  • NP_001121093.1:p.Arg51Trp
  • NC_000001.10:g.24125191G>A
  • NM_000403.3:c.151C>T
  • NM_001127621.2:c.151C>T
Protein change:
R51W; ARG51TRP
Links:
OMIM: 606953.0009; dbSNP: rs780517804
NCBI 1000 Genomes Browser:
rs780517804
Molecular consequence:
  • NM_000403.4:c.151C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001008216.2:c.151C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127621.2:c.151C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
UDPglucose-4-epimerase deficiency
Synonyms:
GALACTOSEMIA III; Galactose epimerase deficiency; UDP-Galactose-4-epimerase deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009257; MedGen: C0751161; Orphanet: 352; OMIM: 230350

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001443734Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Nov 11, 2019)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001569152Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 4, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV002014562GeneReviews
no classification provided
not providedgermlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV003924283Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(May 8, 2023)
germlineresearch

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing, research
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, literature only

Citations

PubMed

A Case of UDP-Galactose 4'-Epimerase Deficiency Associated with Dyshematopoiesis and Atrioventricular Valve Malformations: An Exceptional Clinical Phenotype Explained by Altered N-Glycosylation with Relative Preservation of the Leloir Pathway.

Febres-Aldana CA, Pelaez L, Wright MS, Maher OM, Febres-Aldana AJ, Sasaki J, Jayakar P, Jayakar A, Diaz-Barbosa M, Janvier M, Totapally B, Salyakina D, Galvez-Silva JR.

Mol Syndromol. 2020 Dec;11(5-6):320-329. doi: 10.1159/000511343. Epub 2020 Oct 29.

PubMed [citation]
PMID:
33510604
PMCID:
PMC7802442

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818
See all PubMed Citations (4)

Details of each submission

From Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego, SCV001443734.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant has been previously reported as a homozygous change in multiple affected individuals from the same kindred with histories of thrombocytopenia, intracranial bleeding, anemia, and febrile neutropenia (PMID: 30247636). The variant segregated with disease in this kindred. Functional characterization of the variant protein demonstrated significantly lower enzymatic activity and greatly increased thermal instability (PMID: 30247636). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.002% (4/245814) and thus is presumed to be rare. The c.151C>T (p.Arg51Trp) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Based on the available evidence, the c.151C>T (p.Arg51Trp) variant is classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001569152.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 51 of the GALE protein (p.Arg51Trp). This variant is present in population databases (rs780517804, gnomAD 0.02%). This missense change has been observed in individual(s) with GALE-related conditions and/or thrombocytopenia (PMID: 30247636, 33510604). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 984932). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects GALE function (PMID: 30247636). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneReviews, SCV002014562.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Segregated with thrombocytopenia in a consanguineous family

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, SCV003924283.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Aug 4, 2024